Harmonized Index of Consumer Prices: Pharmaceutical Products for European Union
CP0611EUCCM086NEST • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
120.20
Year-over-Year Change
2.05%
Date Range
12/1/1999 - 7/1/2025
Summary
The Harmonized Index of Consumer Prices (HICP) for Pharmaceutical Products in the European Union measures changes in the prices paid by consumers for a basket of pharmaceutical goods and services over time. This index is a key economic indicator used to track and analyze trends in consumer spending and inflationary pressures.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The HICP for Pharmaceutical Products is a subindex of the broader HICP, which is the main measure of inflation in the EU. It tracks the prices of a representative sample of pharmaceutical products, including prescription drugs, over-the-counter medications, and related healthcare services. This index is used by policymakers, analysts, and researchers to understand consumer behavior and the drivers of medical costs.
Methodology
The HICP data is collected through surveys of a representative sample of retailers and service providers across the EU.
Historical Context
The HICP for Pharmaceutical Products is an important input for monetary and fiscal policy decisions made by the European Central Bank and national governments.
Key Facts
- The HICP for Pharmaceutical Products is a subindex of the broader Harmonized Index of Consumer Prices (HICP).
- This index is used to track changes in consumer spending on pharmaceutical products in the European Union.
- The HICP for Pharmaceutical Products is an important economic indicator for policymakers and analysts.
FAQs
Q: What does this economic trend measure?
A: The Harmonized Index of Consumer Prices (HICP) for Pharmaceutical Products measures changes in the prices paid by consumers for a basket of pharmaceutical goods and services in the European Union.
Q: Why is this trend relevant for users or analysts?
A: This index is an important indicator of consumer spending and inflationary pressures in the healthcare sector, which is relevant for policymakers, economists, and market analysts.
Q: How is this data collected or calculated?
A: The HICP data is collected through surveys of a representative sample of retailers and service providers across the European Union.
Q: How is this trend used in economic policy?
A: The HICP for Pharmaceutical Products is an input for monetary and fiscal policy decisions made by the European Central Bank and national governments in the EU.
Q: Are there update delays or limitations?
A: The HICP data is published monthly with a relatively short delay, but may be subject to revisions over time.
Related Trends
Harmonized Index of Consumer Prices: Mineral Waters, Soft Drinks, Fruit and Vegetable Juices for European Union (27 Countries from 2020)
CP0122EU272020M086NEST
Harmonized Index of Consumer Prices: Photographic and Cinematographic Equipment and Optical Instruments for European Union
CP0912EUCCM086NEST
Harmonized Index of Consumer Prices: Administered Prices for European Union
AP0000EUCCM086NEST
Harmonized Index of Consumer Prices: Bread and Cereals for European Union
CP0111EUCCM086NEST
Employed Population: Aged 55-64: Males for the European Union
LFEM55MAEUA647N
Producer Prices Index: Total Intermediate Goods for the European Union
PITGIG01EUA661N
Citation
U.S. Federal Reserve, Harmonized Index of Consumer Prices: Pharmaceutical Products for European Union (CP0611EUCCM086NEST), retrieved from FRED.